2004
DOI: 10.1016/j.mrfmmm.2004.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of mammary cancer chemoprevention by organoselenium compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
93
0
3

Year Published

2005
2005
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 171 publications
(98 citation statements)
references
References 56 publications
2
93
0
3
Order By: Relevance
“…In addition to its antioxidant functions, Se is needed for a variety of other functions including neutrophil responses to pathogens [166], cell cycling [167], and metabolism of carcinogens [168].…”
Section: Seleniummentioning
confidence: 99%
“…In addition to its antioxidant functions, Se is needed for a variety of other functions including neutrophil responses to pathogens [166], cell cycling [167], and metabolism of carcinogens [168].…”
Section: Seleniummentioning
confidence: 99%
“…The anticancer activity of selenium is well documented (Ip et al, 2002;El Bayoumy and Sinha, 2004). Selenomethionine is the reagent of choice in a number of human intervention trials with prostate cancer.…”
Section: Introductionmentioning
confidence: 99%
“…To date, the use of the micronutrient, selenium, in human clinical trials is limited, but the outcomes of these investigations indicate that selenium is a most promising agents [8]. The trace element selenium has been implicated in chemoprevention and drug-resistance through the reduction of oxidative stress.…”
mentioning
confidence: 99%
“…Synthetic organoselenium compounds inhibit the initiation phase of carcinogenesis by inhibiting DMBA-DNA adduct formation in the target organ in vivo. cDNA microarray analysis has indicated that selenium compounds alter genes in a manner that leads to inhibition of cell proliferation and induction of apoptosis, and modulation of apoptosis and cell proliferation can account for chemoprevention during the post-initiation phase of mammary carcinogenesis [8].…”
mentioning
confidence: 99%